Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...

Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...

The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...

A North Texas woman with a cautionary tale warns others to do their research before starting popular weight loss drugs.

Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

Trump signs executive order, discussed "overweight" friend who was taking the "fat shot drug." It wasn't confirmed whether he meant Ozempic or Wegovy.

Just three days after the Pfizer news, Eli Lilly announced positive results from its Phase III trial of weight-loss drug candidate orforglipron. However, these results are just one part of the ...

News Reporter Eric Stonestreet, the actor known for playing Cam on Modern Family, is teaming up with his mother to sell the weight-loss drug Mounjaro ... giant Eli Lilly. Like better-known ...

INDIANAPOLIS — Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from rival ...

INDIANAPOLIS — Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from rival ...